# US 2014/0236616 A1 · Method for Managing a Therapeutic Substance Regimen

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0236616 A1
- Document ID: US20140236616A1
- Status: Published application
- Kind: A1
- Application number: 14/185,110
- Filed: 2014-02-20
- Published: 2014-08-21
- Earliest claimed: 2013-02-20
- Assignees: Mango Health Inc.
- Applicants: Mango Health Inc.
- Inventors: Jason Oberfest; Gerald Cheong
- Web page: https://patentgrep.com/patent/US20140236616A1

## CPC

- G06Q 10/10: Office automation; Time management
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 40/67: for remote operation
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A method and system for managing a therapeutic substance regimen including: receiving therapeutic substance information from a user; receiving information regarding a regimen; providing interaction information based on the therapeutic substance information; receiving an ascertainment of adherence to the regimen at a set of time points; generating an adherence metric based upon the ascertainment and the set of time points; providing a reward to the user based on the adherence metric; and providing an automated notification to the user based upon at least one of the ascertainment, the adherence metric, and the reward. The method can further comprise providing an advertisement to the user based on one of the therapeutic substance information and the regimen, generating a comparison of the adherence metric for the user to the adherence metric for a second user, and generating an automated refill or renewal request based upon the therapeutic substance information and the regimen.

## Claims

### Claim 1

A method for managing therapeutic substance usage by a user, comprising:
receiving therapeutic substance information pertaining to a set of therapeutic substances, from the user at a user interface;
generating an interaction analysis between a first therapeutic substance and a second therapeutic substance of the set of therapeutic substances;
receiving information regarding a therapeutic substance regimen for consumption of the set of therapeutic substances, at the user interface;
receiving an ascertainment of adherence to the therapeutic substance regimen by the user at a set of time points, at the user interface, wherein receiving the ascertainment includes providing an imaging module, configured to acquire image data of at least one of the set of therapeutic substances, to the user;
automatically generating a request for at least one of a refill and a renewal of one of the set of therapeutic substances, based upon the ascertainment of adherence and the set of time points;
generating a value of an adherence metric based upon the ascertainment of adherence and the set of time points;
providing a reward to the user based upon the value of the adherence metric;
generating a second value of the adherence metric based upon information for at least one other user;
generating a comparison between the value and the second value of the adherence metric;
providing an automated notification to the user pertaining to at least one of the interaction analysis, the request, the value of the adherence metric, the reward, and the comparison; and
automatically providing an advertisement to the user based upon at least one of the therapeutic substance information and the reward.

### Claim 2 (depends on 1)

The method of claim 1, wherein generating the second value of the adherence metric includes generating the second value of the adherence metric based upon data from a second user consuming a second set of therapeutic substances, wherein the second set of therapeutic substances is not identical to the set of therapeutic substances.

### Claim 3 (depends on 1)

The method of claim 1, wherein providing an automated notification includes providing a notification at least at one of a message client and a display of a mobile device of the user.

### Claim 4 (depends on 1)

The method of claim 1, wherein receiving the therapeutic substance information includes receiving an image dataset of at least one of the set of therapeutic substances from the imaging module, and extracting a portion of the therapeutic substance information from the image dataset based upon a detection algorithm.

### Claim 5

A method for managing therapeutic substance usage by a user and promoting a behavior change of the user, the method comprising:
receiving therapeutic substance information pertaining to a therapeutic substance, from the user at a user interface;
receiving information regarding a therapeutic substance regimen for consumption of the therapeutic substance;
receiving an ascertainment of adherence to the therapeutic substance regimen by the user at a set of time points, at the user interface;
generating a value of an adherence metric based upon the ascertainment of adherence to the therapeutic substance regimen and the set of time points;
providing a reward to the user based upon the value of the adherence metric;
generating a second value of the adherence metric based upon information for at least one other user;
generating a comparison between the value and the second value of the adherence metric; and
providing an automated notification to the user pertaining to at least one of the value of the adherence metric, the reward, and the comparison, thereby promoting the behavior change of the user.

### Claim 6 (depends on 5)

The method of claim 5, wherein receiving information regarding the therapeutic substance regimen includes receiving information from at least one of the user at a user input device coupled to the user interface, and a healthcare provider administrating the therapeutic substance to the user.

### Claim 7 (depends on 5)

The method of claim 5, wherein receiving the ascertainment of adherence to the therapeutic substance regimen includes providing a set of instructions to the user upon detection that the user has missed a dose of the therapeutic substance.

### Claim 8 (depends on 5)

The method of claim 5, further including providing an imaging module configured to acquire image data of the therapeutic substance, to the user, wherein at least one of receiving the therapeutic substance information and receiving an ascertainment of adherence to the therapeutic substance regimen includes receiving an image dataset of the therapeutic substance from the imaging module, and extracting a portion of the therapeutic substance information from the image dataset based upon a detection algorithm.

### Claim 9 (depends on 5)

The method of claim 5, wherein generating the value of the adherence metric includes generating a first quantity characterizing correct adherence to the therapeutic substance regimen by the user, a second quantity characterizing incorrect adherence to the therapeutic substance regimen by the user, and a derivative value based upon the first quantity and the second quantity, and wherein generating the second value of the adherence metric includes generating an aggregate version of the derivative value, derived from a population of users.

### Claim 10 (depends on 9)

The method of claim 9, wherein generating the comparison includes rendering a graphic representing the derivative value for the user, and a second graphic representing the aggregate version of the derivative value at a display of the user interface.

### Claim 11 (depends on 5)

The method of claim 5, further including automatically providing an advertisement to the user based upon at least one of the therapeutic substance information and the reward.

### Claim 12 (depends on 11)

The method of claim 11, further including receiving a supplementary dataset, including a substantially real-time location of the user, wherein providing the advertisement to the user includes providing the advertisement for a vendor in proximity to the user, based upon the therapeutic substance information and the substantially real-time location of the user.

### Claim 13

A method for managing therapeutic substance usage by a user, comprising:
receiving therapeutic substance information pertaining to a set of therapeutic substances, from the user at a user interface;
generating an interaction analysis between a first therapeutic substance and a second therapeutic substance of the set of therapeutic substances;
receiving information regarding a therapeutic substance regimen for consumption of the set of therapeutic substances;
receiving an ascertainment of adherence to the therapeutic substance regimen by the user at a set of time points, at the user interface;
automatically generating a request for at least one of a refill and a renewal of one of the set of therapeutic substances, based upon the ascertainment of adherence and the set of time points;
generating a value of an adherence metric based upon the ascertainment of adherence and the set of time points;
providing a reward to the user based upon the value of the adherence metric;
providing an automated notification to the user pertaining to at least one of the interaction analysis, the request, the value of the adherence metric, and the reward.

### Claim 14 (depends on 13)

The method of claim 13, wherein at least one of receiving therapeutic substance information pertaining to a set of therapeutic substances and receiving information regarding the therapeutic substance regimen includes: receiving information from a healthcare provider administrating one of the set of therapeutic substances to the user.

### Claim 15 (depends on 13)

The method of claim 13, wherein automatically generating the request includes generating an estimated time at which the user will fully exhaust a therapeutic substance of the set of therapeutic substance, based upon a determined quantity of the therapeutic substance and the ascertainment; automatically notifying a therapeutic substance provider of the request prior to the estimated time; and receiving notification from the therapeutic substance provider upon fulfillment of the request.

### Claim 16 (depends on 15)

The method of claim 15, wherein receiving the ascertainment of adherence to the therapeutic substance regimen includes providing a set of instructions to the user upon detection that the user has missed a dose of at least one of the set of therapeutic substances.

### Claim 17 (depends on 13)

The method of claim 13, wherein generating the value of the adherence metric includes generating a first quantity characterizing correct adherence to the therapeutic substance regimen by the user, a second quantity characterizing incorrect adherence to the therapeutic substance regimen by the user, and a derivative value based upon the first quantity and the second quantity, and wherein the method further includes: generating an aggregate version of the derivative value, derived from a population of users; and providing the derivative value and the aggregate version of the derivative value to the user at the user interface.

### Claim 18 (depends on 13)

The method of claim 13, further including providing an imaging module configured to acquire image data of at least one of the set of therapeutic substances, to the user, wherein at least one of receiving the therapeutic substance information and receiving an ascertainment of adherence to the therapeutic substance regimen includes receiving an image dataset of at least one of the set of therapeutic substances from the imaging module, and extracting a portion of the therapeutic substance information from the image dataset based upon a detection algorithm.

### Claim 19 (depends on 13)

The method of claim 13, further including automatically providing an advertisement to the user based upon at least one of the therapeutic substance information and the reward.

### Claim 20 (depends on 19)

The method of claim 19, further including receiving a supplementary dataset, including a substantially real-time location of the user, wherein providing the advertisement to the user includes providing the advertisement for a vendor in proximity to the user, based upon the therapeutic substance information and the substantially real-time location of the user.
